《大行報告》瑞信料內險次季新業務價值持續有較強增長 偏好國壽(02628.HK)及中國平安(02318.HK)
瑞信發表報告指,內險股近期股價反彈,相信是自3月底以來強勁的新業務價值增長推動,並預計中國銀保監會將在第二季底宣布將傳統產品的定價利率(PIR)上限從3.5%改為3%,因此預料第二季新業務價值按季增長將持續有較強增長,而勢頭料在第三季因前期需求而放緩。
該行預計,全年內險新業務價值增長雙位數。雖然定價利率較低,但由於保證本金和收益的獨特功能,以及具競爭力的3%收益率,相信保險產品作為一種財務規劃方案仍然具有吸引力。
瑞信表示,偏好國壽(02628.HK),料其第二季度新業務價值增長加速,而且償付能力強,有明確的派息政策。該行同時偏好中國平安(02318.HK),因為壽險改革方面取得進展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.